Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate

Modern Rheumatology

Volumn 22, Issue 3, 2012, Pages 470-473

  Watanabe, Keisuke ^a   Takase, Kaoru ^a   Ohno, Shigeru ^a   Ideguchi, Haruko ^a   Nozaki, Akito ^a   Ishigatsubo, Yoshiaki ^b  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Hepatitis B; Methotrexate; Rheumatoid arthritis

Indexed keywords

AMINOTRANSFERASE; ENTECAVIR; GLYCYRRHIZIC ACID; HEPATITIS B ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG PULSE THERAPY; EPIGASTRIC PAIN; FECES COLOR; FEMALE; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION; MALAISE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URINE COLOR; VIRUS ACTIVATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; METHOTREXATE; MIDDLE AGED; VIRUS ACTIVATION;

EID: 84865362085     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0521-9     Document Type: Article

References (16)

1. Umemura T, Tanaka E, Kiyosawa K, Kumada H, Japan de novo Hepatitis B Research Group, et al. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis. 2008;47:e52-6.
2. Flowers MA, Heathcote J, Wanless IR, Sherman M, Reynolds WJ, Cameron RG, et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of lowdose methotrexate therapy. Ann Intern Med. 1990;112:381-2. (Pubitemid 20083615)
3. Narva'ez J, Rodriguez-Moreno J, Martinez-Aguilá MD, Clavaguera MT. Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy. J Rheumatol. 1998;25:2037-8.
4. Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N, et al. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis Rheum. 2001;44:339-42. (Pubitemid 32207027)
5. Hagiyama H, Kubota T, Komano Y, Kurosaki M, Watanabe M, Miyasaka N. Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis. Clin Exp Rheumatol. 2004;22:375-6. (Pubitemid 38585245)
6. Gwak GY, Koh KC, Kim HY. Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen- negative patient with rheumatoid arthritis receiving low dose methotrexate. Clin Exp Rheumatol. 2007;25:888-9. (Pubitemid 351166443)
7. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2:1104-8. (Pubitemid 26338629)
8. Chou CK, Wang LH, Lin HM, Chi CW. Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells. Hepatology. 1992;16:13-8.
9. Charpin C, Guis S, Colson P, Borentain P, Matte'i JP, Alcaraz P, et al. Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: Results from a cohort of 21 patients. Arthritis Res Ther. 2009;11:R179.
10. Urata Y, Uesato R, Tanaka D, Kowatari K, Nitobe T, Nakamura Y, et al. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients. Mod Rheumatol. 2011;21:16-23.
11. Vassilopoulos D, Apostolopoulou A, Hadziyannis E, Papatheodoridis GV, Manolakopoulos S, Koskinas J, et al. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis. 2010;69:1352-5.
12. Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology. 2006;131:59-68. (Pubitemid 44015749)
13. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatol Int. 2008;2:263-83.
14. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol. 2009;50:227-42.
15. Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009.
16. Hepatology. 2009;50:661-2.